Compugen Ltd at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Good morning, everybody. It's Albert Wong from Morgan Stanley. Welcome to the third day of our Virtual Health Care Conference. I have with us Compugen, very exciting company based in Israel.
I will hand it off to Anat, the CEO; and Ari, the CFO, who can introduce the rest of the team. And we will go through a presentation for a few minutes and then open it up to Q&A. Anat?
Thank you, Albert, and thank you for Morgan Stanley to invite us to the conference. Today, with me today, as Albert was saying, Ari Krashin, the CFO of the company. But also Dr. Henry Adewoye, the CMO of the company; and Dr. Eran Ophir, which is heading the research and drug discovery at Compugen. And I'll start with a brief overview we'll go to the Q&A.
You can look at Slide #3. Compugen is a therapeutic discovery and development company. We discover new drug targets, and we developed first-in-class drugs to address these drug targets. We're focusing the field of cancer
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
